#WHO

The social media platform will use pop-ups to educate users about vaccines with info from credible health agencies.

The global health organization hopes to apply lessons learned from its work with HIV.

Can we really eliminate viral hepatitis? A look at where we are and where we can be.

An international coalition made the lofty promise at last year’s World Hepatitis Summit, but few are delivering, according to WHO.

The move could help dramatically expand access to affordable hep C treatment around the world.

The update includes a new combination therapy that can treat all six genotypes of HCV, a new HIV medication and PrEP.

Highlights from research presented at the 52nd International Liver Congress in Amsterdam

Hepatitis B and C kill an estimated 1.4 million people worldwide every year, yet less than 5 percent of people are aware of their status.

A critical tool that stops the spread of nearly half of all new chronic hepatitis B infections has fallen victim to politics.

#WorldHepDay is celebrated on July 28 to help raise awareness for viral liver disease and promote access to treatment across the globe.

Innovative approaches are needed to get more people tested for hepatitis. Check out the finalists of the #HepTestContest on social media.

This past weekend, 194 countries voted in favor of a historic new initiative that aims to eradicate HCV and HBV as global health threats.

Experts say this is the first global estimate ever recorded on the prevalence of HIV/HCV coinfection as a public health concern.

The World Health Organization has called for a major increase in the worldwide treatment of hepatitis B and C.

The Glasgow summit aims to help countries combat viral hepatitis and expand access to treatment.

The World Health Organization (WHO) has added the new hepatitis C medications to its Model List of Essential Medicines.